{"id":{"repo_id":"mcmaster","oai_identifier":"oai:macsphere.mcmaster.ca:11375/33816"},"canonical_url":"https://search.ndltd.org/etd/mcmaster/oai:macsphere.mcmaster.ca:11375/33816","repository":{"repo_id":"mcmaster","name":"McMaster University","base_url":"https://macsphere.mcmaster.ca/server/oai/request"},"display":{"title":"Uteroplacental effects of diet-induced maternal obesity","abstract":"The increasing prevalence of maternal excess adiposity represents a significant global health concern, contributing to a higher risk of pregnancy complications and adverse short- and long-term health outcomes for both mother and offspring. More recently, maternal excess adiposity has been associated with compromised uteroplacental perfusion and placental hypoxia, yet the vascular changes contributing to these outcomes are not entirely understood. Chronic low-grade inflammation and a pro-coagulant state driven by excess adiposity may activate endothelial cells across the maternal peripheral, decidual, and placental vasculature to impair early vasculogenic processes and alter uteroplacental blood flow. We hypothesized that maternal diet-induced excess adiposity promotes decidual inflammation and endothelial cell (EC) activation early in pregnancy, leading to fibrin deposition, vessel occlusion, and uteroplacental hypoxia at mid- and late-gestation. We tested this hypothesis in mice fed a high-fat, high-sucrose (HFHS) diet for 12 weeks before and throughout pregnancy, assessing uteroplacental tissues at embryonic day (E) 8.5, E12.5, and E18.5. Our data show that HFHS intake resulted in increased uteroplacental hypoxia and vascular occlusions across gestation. The greatest increases in hypoxia and vessel occlusion both occurred in the decidua at mid-gestation, with the most pronounced hypoxic response in tissues supporting male fetuses. We also observed increased old fibrin deposition in the decidua and labyrinth zone (LZ) at E18.5, coinciding with reduced nuclei and loss of MCT-1-positive syncytiotrophoblast in the LZ, suggesting tissue injury. Despite these vascular and hypoxic responses, we found no diet-related differences in positive staining for NF-κB- or ICAM-1-mediated EC activation, although extracellular ICAM-1 was localized to regions of decidual fibrin deposition from mid-gestation onward. Overall, our findings do not point to inflammation-induced EC activation as the primary driver of HFHS-induced uteroplacental pathology. The accumulation of red blood cells and fibrin within occluded vessels, and the persistence of these deposits to term, may instead sustain the hypoxic and pro-coagulant conditions established earlier in gestation. These findings clarify when and where uteroplacental hypoxia arises in pregnancies complicated by excess adiposity and identify the maternal circulation as an area for future investigation.","abstract_html":"The increasing prevalence of maternal excess adiposity represents a significant global health concern, contributing to a higher risk of pregnancy complications and adverse short- and long-term health outcomes for both mother and offspring. More recently, maternal excess adiposity has been associated with compromised uteroplacental perfusion and placental hypoxia, yet the vascular changes contributing to these outcomes are not entirely understood. Chronic low-grade inflammation and a pro-coagulant state driven by excess adiposity may activate endothelial cells across the maternal peripheral, decidual, and placental vasculature to impair early vasculogenic processes and alter uteroplacental blood flow. We hypothesized that maternal diet-induced excess adiposity promotes decidual inflammation and endothelial cell (EC) activation early in pregnancy, leading to fibrin deposition, vessel occlusion, and uteroplacental hypoxia at mid- and late-gestation. We tested this hypothesis in mice fed a high-fat, high-sucrose (HFHS) diet for 12 weeks before and throughout pregnancy, assessing uteroplacental tissues at embryonic day (E) 8.5, E12.5, and E18.5. Our data show that HFHS intake resulted in increased uteroplacental hypoxia and vascular occlusions across gestation. The greatest increases in hypoxia and vessel occlusion both occurred in the decidua at mid-gestation, with the most pronounced hypoxic response in tissues supporting male fetuses. We also observed increased old fibrin deposition in the decidua and labyrinth zone (LZ) at E18.5, coinciding with reduced nuclei and loss of MCT-1-positive syncytiotrophoblast in the LZ, suggesting tissue injury. Despite these vascular and hypoxic responses, we found no diet-related differences in positive staining for NF-κB- or ICAM-1-mediated EC activation, although extracellular ICAM-1 was localized to regions of decidual fibrin deposition from mid-gestation onward. Overall, our findings do not point to inflammation-induced EC activation as the primary driver of HFHS-induced uteroplacental pathology. The accumulation of red blood cells and fibrin within occluded vessels, and the persistence of these deposits to term, may instead sustain the hypoxic and pro-coagulant conditions established earlier in gestation. These findings clarify when and where uteroplacental hypoxia arises in pregnancies complicated by excess adiposity and identify the maternal circulation as an area for future investigation.","abstract_has_math":false,"creators":["Ariana E. Lewis"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":"Biochemistry and Biomedical Sciences","school":null,"contributors":[],"advisors":["Sloboda, Deborah"],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026","date_published":"2026","updated_at":"2026-11-18T19:33:55Z","subjects":[],"languages":["en"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://doi.org/10.71548/25586"],"render_values":[{"text":"https://doi.org/10.71548/25586","href":"https://doi.org/10.71548/25586","code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/11375/33816","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/11375/33816","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://macsphere.mcmaster.ca/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Amacsphere.mcmaster.ca%3A11375%2F33816","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Sloboda, Deborah"]},{"key":"dc:contributor.department","label":"Department","values":["Biochemistry and Biomedical Sciences"]},{"key":"dc:creator","label":"Author","values":["Ariana E. Lewis"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2026-10-14T17:26:50Z"]},{"key":"dc:date.issued","label":"Date","values":["2026"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/11375/33816","https://doi.org/10.71548/25586"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["The increasing prevalence of maternal excess adiposity represents a significant global health concern, contributing to a higher risk of pregnancy complications and adverse short- and long-term health outcomes for both mother and offspring. More recently, maternal excess adiposity has been associated with compromised uteroplacental perfusion and placental hypoxia, yet the vascular changes contributing to these outcomes are not entirely understood. Chronic low-grade inflammation and a pro-coagulant state driven by excess adiposity may activate endothelial cells across the maternal peripheral, decidual, and placental vasculature to impair early vasculogenic processes and alter uteroplacental blood flow. We hypothesized that maternal diet-induced excess adiposity promotes decidual inflammation and endothelial cell (EC) activation early in pregnancy, leading to fibrin deposition, vessel occlusion, and uteroplacental hypoxia at mid- and late-gestation. We tested this hypothesis in mice fed a high-fat, high-sucrose (HFHS) diet for 12 weeks before and throughout pregnancy, assessing uteroplacental tissues at embryonic day (E) 8.5, E12.5, and E18.5. Our data show that HFHS intake resulted in increased uteroplacental hypoxia and vascular occlusions across gestation. The greatest increases in hypoxia and vessel occlusion both occurred in the decidua at mid-gestation, with the most pronounced hypoxic response in tissues supporting male fetuses. We also observed increased old fibrin deposition in the decidua and labyrinth zone (LZ) at E18.5, coinciding with reduced nuclei and loss of MCT-1-positive syncytiotrophoblast in the LZ, suggesting tissue injury. Despite these vascular and hypoxic responses, we found no diet-related differences in positive staining for NF-κB- or ICAM-1-mediated EC activation, although extracellular ICAM-1 was localized to regions of decidual fibrin deposition from mid-gestation onward. Overall, our findings do not point to inflammation-induced EC activation as the primary driver of HFHS-induced uteroplacental pathology. The accumulation of red blood cells and fibrin within occluded vessels, and the persistence of these deposits to term, may instead sustain the hypoxic and pro-coagulant conditions established earlier in gestation. These findings clarify when and where uteroplacental hypoxia arises in pregnancies complicated by excess adiposity and identify the maternal circulation as an area for future investigation."]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["Master of Science (MSc)"]},{"key":"dc:description.sponsorship","label":"Dc Description Sponsorship","values":["CIHR - CGS-M"]},{"key":"dc:title","label":"Title","values":["Uteroplacental effects of diet-induced maternal obesity"]},{"key":"dc:title.alternative","label":"Alternative Title","values":["Maternal obesogenic diet induces uteroplacental hypoxia and vascular occlusions"]},{"key":"others:access_status","label":"Others Access Status","values":["embargo"]}]}],"canonical_facts":{"dc:contributor.advisor":["Sloboda, Deborah"],"dc:contributor.department":["Biochemistry and Biomedical Sciences"],"dc:creator":["Ariana E. Lewis"],"dc:date.accessioned":["2026-10-14T17:26:50Z"],"dc:date.issued":["2026"],"dc:description.abstract":["The increasing prevalence of maternal excess adiposity represents a significant global health concern, contributing to a higher risk of pregnancy complications and adverse short- and long-term health outcomes for both mother and offspring. More recently, maternal excess adiposity has been associated with compromised uteroplacental perfusion and placental hypoxia, yet the vascular changes contributing to these outcomes are not entirely understood. Chronic low-grade inflammation and a pro-coagulant state driven by excess adiposity may activate endothelial cells across the maternal peripheral, decidual, and placental vasculature to impair early vasculogenic processes and alter uteroplacental blood flow. We hypothesized that maternal diet-induced excess adiposity promotes decidual inflammation and endothelial cell (EC) activation early in pregnancy, leading to fibrin deposition, vessel occlusion, and uteroplacental hypoxia at mid- and late-gestation. We tested this hypothesis in mice fed a high-fat, high-sucrose (HFHS) diet for 12 weeks before and throughout pregnancy, assessing uteroplacental tissues at embryonic day (E) 8.5, E12.5, and E18.5. Our data show that HFHS intake resulted in increased uteroplacental hypoxia and vascular occlusions across gestation. The greatest increases in hypoxia and vessel occlusion both occurred in the decidua at mid-gestation, with the most pronounced hypoxic response in tissues supporting male fetuses. We also observed increased old fibrin deposition in the decidua and labyrinth zone (LZ) at E18.5, coinciding with reduced nuclei and loss of MCT-1-positive syncytiotrophoblast in the LZ, suggesting tissue injury. Despite these vascular and hypoxic responses, we found no diet-related differences in positive staining for NF-κB- or ICAM-1-mediated EC activation, although extracellular ICAM-1 was localized to regions of decidual fibrin deposition from mid-gestation onward. Overall, our findings do not point to inflammation-induced EC activation as the primary driver of HFHS-induced uteroplacental pathology. The accumulation of red blood cells and fibrin within occluded vessels, and the persistence of these deposits to term, may instead sustain the hypoxic and pro-coagulant conditions established earlier in gestation. These findings clarify when and where uteroplacental hypoxia arises in pregnancies complicated by excess adiposity and identify the maternal circulation as an area for future investigation."],"dc:description.degree":["Master of Science (MSc)"],"dc:description.sponsorship":["CIHR - CGS-M"],"dc:identifier.uri":["https://hdl.handle.net/11375/33816","https://doi.org/10.71548/25586"],"dc:language.iso":["en"],"dc:title":["Uteroplacental effects of diet-induced maternal obesity"],"dc:title.alternative":["Maternal obesogenic diet induces uteroplacental hypoxia and vascular occlusions"],"dc:type":["Thesis"],"others:access_status":["embargo"]},"updated_at":"2026-11-18T19:33:55Z"}